Hip and thigh

Z21_HIP_THIGH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — ZA5.1 Cause of death: ICD-10 — ZA5.1 2 out of 7 registries used, show all original rules.	94
4. Check minimum number of events None	94
5. Include endpoints None	94
6. Filter based on genotype QC (FinnGen only)	88

Control definitions (FinnGen only)

Control exclude: Z21_ADDIT_CODES_LOCAT_DEFECT_INJURY_ILLNE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[AB]

NAME	Z21_HIP_THIGH
CONTROL_EXCLUDE	Z21_ADDIT_CODES_LOCAT_DEFECT_INJURY_ILLNE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	ZA51
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	ZA51
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hip and thigh based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	88	59	29
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	64.16	60.47	71.67

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
94: Matched controls
940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZA5.1

ICD-10 Finland

Hip and thigh

+∞

130.3

NF1AA

NOMESCO Finland

Hip X-ray examination

11.4

24.6

M16.1

ICD-10 Finland

Other primary coxarthrosis

6.8

15.3

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

7.2

13.7

L13

ICPC

Hip symptom/complaint

4.8

11.7

113

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

24.6

8.2

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

7.4

8.1

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

17.5

7.4

M79.6

ICD-10 Finland

Pain in limb

3.2

7.0

297

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

8.7

6.4

N02AX02

ATC

tramadol; systemic, rectal

2.9

6.2

287

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

136

2.77

4.66

5.1

3.9

24.38

94.79

ng/l

1.18

107

(3044941) Cell count panel - Synovial fluid

14.96

4.65

1.1

1.2

—

(3006315) Basophils [#/volume] in Blood

382

2.58

4.62

9.0

6.1

0.04

e9/l

1.12

330

(3001604) Monocytes [#/volume] in Blood

382

2.58

4.62

9.0

6.1

0.60

0.58

e9/l

0.21

330

(3019198) Lymphocytes [#/volume] in Blood

396

2.42

4.07

9.1

6.1

1.94

1.85

e9/l

0.43

351

(3013115) Eosinophils [#/volume] in Blood

396

2.42

4.07

10.5

6.5

0.27

0.17

e9/l

0.93

347

(3023368) Bacteria identified in Blood by Culture

205

2.33

3.67

4.9

4.2

—

(3021788) Differential panel - Synovial fluid

10.56

3.55

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

452

2.30

3.48

13.1

9.3

3.88

4.21

e9/l

0.60

396

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4.73

3.42

1.3

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.70

3.39

8.5

7.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

287

2.18

3.37

3.6

3.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

359

2.18

3.37

11.1

6.8

—

(3003396) Base excess in Arterial blood by calculation

2.62

3.33

8.5

6.1

2.28

1.97

mmol/l

0.12

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

352

2.16

3.29

3.2

2.4

—

(3042936) Bacteria identified in Isolate by Culture

115

2.46

3.24

2.2

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

545

2.37

3.17

5.8

4.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

170

2.23

3.08

2.3

2.7

1.20

1.07

mg/l

0.15

135

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

135

2.28

2.92

1.2

27.03

3.91

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

5.31

2.78

1.7

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

8.71

2.78

1.0

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.03

2.75

1.3

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

372

1.97

2.64

9.6

8.3

1.23

1.22

mmol/l

0.34

326

(3022217) INR in Platelet poor plasma by Coagulation assay

358

1.93

2.49

8.5

15.5

1.14

1.31

inr

0.55

111

(3018095) Leukocytes [#/volume] in Urine

288

1.91

2.40

4.3

3.9

128.93

63.33

e6/l

0.35

216

(3002582) Erythrocytes [#/volume] in Urine

256

1.89

2.29

3.5

3.3

36.01

282.78

e6/l

0.51

203

(3026008) Bacteria identified in Urine by Culture

256

1.89

2.29

3.8

3.2

—

(3019150) Specific gravity of Urine by Refractometry

173

1.98

2.25

3.1

4.4

1.01

1.02

kg/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

457

1.87

2.16

7.4

5.0

6.76

6.67

mmol/l

0.12

423

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

160

1.96

2.12

2.6

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

100

2.13

2.04

1.3

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

2.08

1.86

1.3

1.4

160.00

833.85

titre

—

(3044889) 12 lead EKG panel

532

1.81

1.83

3.5

3.8

—

(3048689) Calprotectin [Mass/mass] in Stool

2.06

1.74

1.5

2.1

90.77

157.90

ug/g

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

179

1.80

1.72

3.2

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

593

1.81

1.65

4.5

4.0

14.69

14.84

pmol/l

0.20

536

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

3.71

1.63

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

3.13

1.61

2.5

1.1

1.00

2.80

e6/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.13

1.61

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

3.46

1.54

2.8

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.98

1.53

2.0

1.6

0.25

0.22

g/l

—

(3018418) pH of Serum or Plasma

229

1.68

1.51

4.8

4.6

7.39

7.40

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

331

1.62

1.47

3.1

2.8

110.14

108.95

ug/l

0.02

309

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.84

1.46

2.0

1.5

1.26

1.17

g/l

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

121

1.83

1.45

5.8

5.6

0.75

0.80

mmol/l

1.32

110

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.15

1.45

1.2

1.8

—

(3012516) Albumin [Mass/volume] in Urine

206

1.67

1.42

4.3

3.2

1407.11

74.67

mg/l

0.47

134

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.32

1.41

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.71

1.39

1.2

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.26

1.38

10.1

8.0

95.46

93.45

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

825

2.48

1.36

23.7

16.4

77.64

77.29

umol/l

0.05

825

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

140

1.75

1.36

1.4

1.3

95.17

33.74

iu/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.60

1.32

1.2

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.93

1.29

1.5

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

230

1.59

1.25

2.9

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

2.39

1.20

2.0

3.5

—

(36304419) Bacteria [Presence] in Urine

223

1.58

1.20

3.9

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

232

1.58

1.20

3.8

3.2

0.53

0.36

e6/l

0.15

177

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

501

1.55

1.19

3.5

3.0

42.13

43.00

u/l

0.04

475

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

1.18

0.0

3.9

—

46.52

—

(3019060) Gas panel - Arterial blood

2.02

1.17

4.0

4.2

—

(3035350) Ketones [Presence] in Urine by Test strip

394

1.51

1.14

4.2

4.1

0.00

estimate

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.04

1.12

1.5

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.04

1.12

22.6

5.1

25.38

24.17

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.77

1.08

2.2

1.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.82

1.05

2.3

1.8

310.08

378.00

nmol/l

0.42

(3028026) IgM [Mass/volume] in Serum or Plasma

1.97

1.04

1.6

2.1

0.75

1.24

g/l

—

(3009261) Glucose [Presence] in Urine by Test strip

401

1.46

1.01

4.2

4.0

0.00

estimate

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.73

1.01

2.1

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

394

1.45

0.96

5.5

5.8

0.00

estimate

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.22

0.93

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.22

0.93

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.22

0.93

1.0

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.88

0.92

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.14

0.91

2.3

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

488

1.43

0.88

3.6

3.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

131

1.56

0.87

3.1

3.2

2.71

2.00

e6/l

0.23

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.00

0.86

1.3

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

185

1.48

0.84

2.1

2.60

3.02

mg/l

0.37

164

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.77

0.83

6.6

4.1

5.08

4.51

pmol/l

—

(1761868) Lipid panel - Serum or Plasma

282

0.67

0.82

2.6

3.0

—

(3029937) Albumin [Presence] in Urine by Test strip

214

1.44

0.80

4.8

3.9

0.00

estimate

—

(3020682) Albumin/Creatinine [Ratio] in Urine

224

1.43

0.78

4.7

3.7

4.55

10.87

mg/mmol

1.20

135

(3005719) IgG [Mass/volume] in Serum or Plasma

1.74

0.77

2.4

3.5

9.33

9.24

g/l

—

(3003694) ABO and Rh group [Type] in Blood

190

1.43

0.73

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

311

1.37

0.73

4.4

4.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.97

0.72

1.4

1.3

—

(40768797) Stomach Pathology biopsy report

103

1.54

0.70

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.72

0.70

1.1

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.90

0.69

1.2

1.8

—

(3022313) Gas panel - Capillary blood

1.68

0.68

5.9

11.2

—

(3000991) Gas panel - Venous blood

1.69

0.68

24.0

8.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

140

1.45

0.65

3.1

3.0

0.75

0.95

e6/l

0.20

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.69

0.64

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

317

1.33

0.63

3.1

4.2

27.13

32.78

ng/l

0.23

220

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.70

0.62

1.0

—

(4034850) Laboratory test

0.00

0.61

0.0

14.9

—

(3000494) Fungus identified in Specimen by Culture

1.50

0.61

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

319

1.32

0.60

2.3

2.0

93.44

95.21

pmol/l

0.09

165

(40758558) Short blood count panel - Blood

216

1.35

0.58

13.5

7.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.42

0.52

4.3

3.1

65.24

65.46

g/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

129

1.39

0.50

2.1

2.0

—

(3021589) Normoblasts [#/volume] in Blood

346

1.27

0.49

15.0

9.5

0.00

e9/l

0.50

283

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.59

0.48

2.8

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

167

1.33

0.47

1.5

1.4

2.23

2.39

g/l

0.15

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.46

0.47

30.7

11.6

26.29

24.85

mmol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

186

1.31

0.46

1.1

1.2

0.74

1.15

u/ml

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1.47

0.44

5.6

9.6

5.39

5.01

kpa

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.41

0.0

2.9

—

16.45

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(1616796) Gas panel - Central venous blood

0.00

0.41

0.0

3.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

134

1.33

0.40

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.39

0.0

3.2

—

8.68

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.39

0.0

3.2

—

4.90

—

(3012501) Base excess in Blood by calculation

0.00

0.39

0.0

3.2

—

2.22

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.39

0.0

1.4

—

(40768443) Skin Pathology biopsy report

1.41

0.39

1.4

1.2

—

(40761511) CBC panel - Blood by Automated count

816

1.43

0.38

18.6

13.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.49

0.37

1.5

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.42

0.36

2.0

2.8

—

(3022145) Colonoscopy Study observation

0.64

0.34

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.35

0.34

4.5

9.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.40

0.32

1.7

2.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

139

1.27

0.32

1.8

—

(40761535) Cells panel - Urine sediment

1.29

0.28

3.0

3.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.30

0.25

4.5

3.5

2.09

1.76

1.01

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.21

0.0

2.3

—

90.78

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

2.40

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.21

0.0

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3000012) Reticulocyte production index

0.00

0.21

0.0

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

4.5

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

3.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

0.97

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.2

—

1.68

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.20

0.0

2.8

—

3.92

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.20

0.0

2.8

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.20

0.0

2.8

—

108.36

—

(3019225) pH of Specimen

0.72

0.17

2.4

5.7

—

(40761536) Microorganisms panel - Urine sediment

0.72

0.17

3.4

3.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

168

1.16

0.17

4.8

4.9

23.50

21.94

0.17

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.17

0.17

1.6

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.22

0.17

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.12

0.16

1.5

1.7

—

(40768804) Tissue Pathology biopsy report

324

0.89

0.15

2.4

2.0

—

(3002256) Pathology report gross observation

0.77

0.15

1.9

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

232

1.11

0.11

4.5

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.14

0.10

1.2

1.7

—

(3025941) Bacteria identified in Stool by Culture

1.04

0.09

1.6

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.08

0.09

2.7

4.1

1.25

1.22

mmol/l

—

(3000492) Spirometry study

1.04

0.08

1.7

1.8

—

(3022621) pH of Urine by Test strip

0.80

0.08

3.0

2.6

—

(36660697) Celiac disease serology panel - Serum

1.10

0.08

1.3

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.06

0.07

1.5

1.7

—

(3013512) EKG study

231

1.05

0.03

3.1

4.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

737

0.96

0.01

17.3

12.9

80.09

79.77

ml/min/173m2

0.04

603

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.05

0.00

8.5

6.1

102.40

103.37

mmol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

109

1.01

0.00

1.9

1.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.5

—

(21494755) Public health laboratory ask at order entry panel

1.02

-0.00

1.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.7

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.3

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

231.00

—

(3036603) Volume of Urine

0.00

-0.00

0.0

1.4

—

1561.00

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(4200892) Spirometry reversibility

1.02

-0.00

1.7

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

16.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

-0.00

0.0

1.6

—

(4035726) Immunohistochemistry procedure

0.93

-0.00

1.7

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.00

-0.00

1.1

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.7

—

0.67

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

140

1.00

-0.00

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

50.33

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.5

—

1.19

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.89

-0.00

2.0

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

23.80

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

8.28

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

25.43

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.8

—

32.22

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_HIP_THIGH – Hip and thigh

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hip and thigh

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Hip and thigh (Z21_HIP_THIGH)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints